B3GALT5 and cancer: Similarly, in multivariate analysis, RFS and OS were both correlated with the higher AJCC cancer stages III–IV (HR = 2.40, P = 7.9E−03, and HR = 3.06, P = 1.0E−04, respectively) and expression of B3GALT5 in adjacent non-tumor tissue (HR = 4.20, P = 5.1E−05, and HR = 2.50, P = 0.02, respectively).